Medication-Assisted Treatment (MAT) for Lasting Recovery
Evidence-based care that brings FDA-approved medications together with behavioral therapy
Understanding Medication-Assisted Treatment
Medication-Assisted Treatment (MAT) brings FDA-approved medications together with counseling and behavioral therapy to support people living with substance use disorders. This whole-person approach tends to both the physical and emotional sides of addiction, meaningfully improving outcomes and reducing the risk of overdose and death.
The Science Behind MAT
MAT works at the level of the brain's opioid receptors — the same receptors affected by drugs like heroin and prescription painkillers. Depending on the specific medication, MAT can fully activate those receptors to prevent withdrawal (agonists), partially activate them to soften cravings (partial agonists), or block them outright so opioid use produces no effect (antagonists).
This pharmacological foundation gives the brain time to heal while a person engages in counseling and rebuilds the rest of their life. Far from "swapping one drug for another," MAT medications are carefully dosed to steady brain chemistry without producing euphoria, so people can function clearly and fully throughout their recovery.
Mat Vs Moud
You may come across several terms for this kind of care. MAT (Medication-Assisted Treatment) is the more traditional label, emphasizing the pairing of medication with therapy. MOUD (Medications for Opioid Use Disorder) is a newer term that puts the focus squarely on the medications themselves, reflecting the evidence that they are effective treatments in their own right — not just an "assist."
MAUD (Medications for Alcohol Use Disorder) follows the same logic for FDA-approved alcohol use disorder medications. Whichever term a clinician uses, the underlying research points the same way: medication combined with behavioral treatment produces the strongest outcomes.
FDA-Approved Medications Used in MAT
Three FDA-approved medications are used to treat opioid use disorder, and three to treat alcohol use disorder. Each works through a different mechanism and is matched to different people, histories, and care settings.
Opioid Medications
Buprenorphine (Suboxone, Subutex, Sublocade) is a partial opioid agonist that eases cravings and withdrawal without producing the full effects of opioids. Its "ceiling effect" means that taking more beyond a certain dose does not increase the effect, which makes it safer than full agonists. Available as sublingual films, tablets, or monthly injections, buprenorphine can be prescribed in office-based settings — putting it within reach for many people. Read more about Suboxone treatment.
Methadone is a full opioid agonist that prevents withdrawal and reduces cravings when taken at properly titrated doses. It has a long clinical history (since 1972) and a strong evidence base. Methadone must be dispensed through certified Opioid Treatment Programs (OTPs), typically with daily clinic visits during the initial stabilization phase. Read more about methadone treatment.
Naltrexone (Vivitrol) is an opioid antagonist that fully blocks the effects of opioids. Available as daily oral tablets or as a monthly extended-release injection, naltrexone requires complete detoxification first (7-14 days opioid-free). It carries no abuse potential and can be prescribed in any medical setting. Read more about Vivitrol treatment.
Alcohol Medications
Naltrexone (ReVia, Vivitrol) blunts the rewarding effects of alcohol and reduces cravings. It can be taken as a daily pill or as a monthly injection, and is sometimes used with "targeted" dosing — taken in advance of situations where drinking is likely.
Acamprosate (Campral) helps restore balance to brain systems disrupted by chronic alcohol use. It works best for maintaining abstinence in people who have already stopped drinking, and pairs especially well with counseling and peer support groups.
Disulfiram (Antabuse) produces an unpleasant reaction when alcohol is consumed, including nausea, headache, and flushing. This aversive approach tends to work best for highly motivated people and in supervised settings where medication adherence can be observed.
How MAT Supports Addiction Recovery
MAT works best when medication is paired with comprehensive behavioral care. That typically means individual counseling, group therapy, and practical support around the things that shape recovery — housing, employment, and family relationships.
What the Treatment Process Looks Like
Care usually begins with a clinical assessment to choose the right medication and starting dose. For buprenorphine, a person needs to be in mild-to-moderate withdrawal before the first dose, to avoid precipitated withdrawal. Methadone can be started right away. Naltrexone requires complete detoxification before the first dose.
Once a stable dose is established, ongoing counseling becomes the heart of the work — most commonly Cognitive Behavioral Therapy (CBT) and/or Motivational Interviewing — to address the psychological side of addiction and build durable coping skills.
Why Medication-Assisted Treatment Helps
Across decades of clinical research, MAT shows clear, consistent improvements in the outcomes that matter most:
- 50% or greater reduction in overdose deaths compared with abstinence-only treatment
- Stronger treatment retention — people stay engaged in care longer and complete treatment more often
- Less illicit drug use — 70% or greater reduction in opioid use
- Lower involvement with the justice system — less drug-seeking behavior and related crime
- Better work and livelihood outcomes — more people able to hold steady employment
- Reduced HIV/Hepatitis C transmission — less injection drug use
- Improved birth outcomes — for pregnant women with OUD
Setting the Record Straight on MAT
Even with strong evidence behind it, MAT is still underused — largely because of persistent myths and stigma. Here is what the research actually says:
Myth Busting
"MAT is just trading one addiction for another." This is the most common misconception. Addiction is defined by compulsive use despite mounting negative consequences. MAT medications, taken as prescribed, do not produce euphoria or impair functioning. They steady brain chemistry so people can work, parent, and rebuild their lives.
"You're not really sober if you're on MAT." The medical community and most major recovery organizations recognize that taking a prescribed medication for a medical condition is not the same as active addiction. Plenty of people on MAT are also active in 12-step programs and other recovery communities.
"MAT should only be short-term." Longer treatment duration is associated with better outcomes in the research. Stopping MAT too early is linked with high relapse rates and increased overdose risk. Many people benefit from indefinite maintenance, much like ongoing medication for any other chronic condition.
Who Tends to Do Well on MAT?
MAT is appropriate for anyone diagnosed with opioid use disorder (OUD) or alcohol use disorder (AUD) who meets clinical criteria. That said, certain groups tend to see especially strong results from medication-assisted care:
- People with moderate-to-severe opioid use disorder — including those dependent on heroin, fentanyl, or prescription painkillers. MAT is the first-line recommended treatment for OUD
- People who have relapsed after abstinence-only treatment — research shows that adding medication meaningfully reduces relapse rates compared with behavioral treatment alone
- People at elevated overdose risk — especially anyone returning to use after a period of abstinence (after incarceration or detox, for example), when tolerance has dropped and overdose risk is at its highest
- Pregnant women with opioid addiction — buprenorphine or methadone is the standard of care during pregnancy, protecting both mother and baby from the dangers of withdrawal and continued use
- People with co-occurring mental health conditions — by steadying brain chemistry, MAT often makes therapy for depression, anxiety, PTSD, and other conditions more productive
- People living with alcohol dependence — naltrexone and acamprosate help reduce cravings and support ongoing sobriety, particularly when combined with counseling
There is no single "typical" MAT patient. People of every age, background, and severity of addiction can benefit. The choice to begin MAT is best made together with your treatment provider, weighing your medical history, substance use patterns, and personal goals.
MAT Across the Full Continuum of Care
One of MAT's greatest strengths is how flexible it is — medications can be woven into nearly every level of addiction care, keeping treatment consistent as a person moves through recovery:
- Medical Detox — Buprenorphine or methadone is often used during detoxification to manage opioid withdrawal safely and comfortably. This is frequently where someone first starts MAT
- Residential/Inpatient Treatment — Many residential programs now build MAT into their model, letting people stabilize on medication while engaging in intensive therapy. This combination addresses both the physical and psychological sides of addiction at once
- Partial Hospitalization (PHP) — Structured daytime treatment continues alongside MAT. This level fits people stepping down from residential care who still need substantial support
- Intensive Outpatient (IOP) — MAT combined with IOP offers room for work and family responsibilities. People typically attend treatment several times per week while continuing their medication
- Standard Outpatient — The most common long-term setting for MAT, with regular provider visits (often monthly once stabilized) combined with ongoing counseling. Suboxone and Vivitrol fit this level especially well
- Telehealth — Since regulatory changes in 2023, buprenorphine can be prescribed via telehealth without requiring an in-person visit first — opening access for people in rural areas or anyone navigating transportation barriers
The core principle here is continuity: medication should travel with a person as they move between levels of care. Interrupting MAT during transitions is one of the leading drivers of relapse and overdose. A strong treatment program plans medication management as carefully as every other piece of the handoff.
Not Sure Where to Start with Treatment?
Look through the directory, or pick up the phone and talk it through.
Showing 0 of 0 treatment centers
No programs to show yet — try a different filter or area.
Quick Answers: Medication-Assisted Treatment
Trusted Resources to Keep Reading
Ready to Take the Next Step?
Search our directory of treatment programs that offer medication-assisted treatment and find the right fit for your recovery — at your own pace.